Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer - PubMed (original) (raw)

Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer

E H Mahlamäki et al. Genes Chromosomes Cancer. 1997 Dec.

Abstract

Comparative genomic hybridization (CGH) was used to screen for genomic imbalances in 24 exocrine pancreatic carcinomas, including II low-passage cell lines (4-8 subcultures) and 13 uncultured samples. Aberrations were found in all cell lines and in seven of the 13 biopsies. The most frequent changes in the cell lines were gains of 20q (91%), 11q (64%), 17q (64%), 19q (64%), 8q, 12p, 14q, and 20p (55%), and losses of 18q (100%), 9p (91%), 15q(73%), 21q (64%), 3p (55%), and 13q (55%). High-levels gains (tumor to normal ratio over 1.5) were detected at 3q, 6p, 7q, 8q, 12p, 19q, and 20q. Among the tumor biopsies, overrepresentations of 7p and 8q were most common (31%), followed by 5p, 5q, 11p, 11q, 12p, and 18q (23%), whereas the most frequent losses involved 18p and 18q (31%) and 6q and 17p (23%). The genetic changes in nine samples obtained from metastatic lesions did not differ significantly from those in 15 primary carcinomas. Most of the gains and losses detected in this CGH study correspond well to those identified in previous cytogenetic and molecular genetic investigations of pancreatic carcinomas. However, frequent gain of 12p and loss of 15q have not been previously reported. Molecular genetic analyses of these chromosome arms are warranted, and may lead to the discovery of novel genes important in pancreatic carcinogenesis.

PubMed Disclaimer

Cited by

Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer.
Bashyam MD, Bair R, Kim YH, Wang P, Hernandez-Boussard T, Karikari CA, Tibshirani R, Maitra A, Pollack JR. Bashyam MD, et al. Neoplasia. 2005 Jun;7(6):556-62. doi: 10.1593/neo.04586. Neoplasia. 2005. PMID: 16036106 Free PMC article.
Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.
Wong N, Lai P, Lee SW, Fan S, Pang E, Liew CT, Sheng Z, Lau JW, Johnson PJ. Wong N, et al. Am J Pathol. 1999 Jan;154(1):37-43. doi: 10.1016/S0002-9440(10)65248-0. Am J Pathol. 1999. PMID: 9916916 Free PMC article.
Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization.
Bleuel K, Popp S, Fusenig NE, Stanbridge EJ, Boukamp P. Bleuel K, et al. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2065-70. doi: 10.1073/pnas.96.5.2065. Proc Natl Acad Sci U S A. 1999. PMID: 10051595 Free PMC article.
High-resolution characterization of the pancreatic adenocarcinoma genome.
Aguirre AJ, Brennan C, Bailey G, Sinha R, Feng B, Leo C, Zhang Y, Zhang J, Gans JD, Bardeesy N, Cauwels C, Cordon-Cardo C, Redston MS, DePinho RA, Chin L. Aguirre AJ, et al. Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9067-72. doi: 10.1073/pnas.0402932101. Proc Natl Acad Sci U S A. 2004. PMID: 15199222 Free PMC article.
Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers.
Burum-Auensen E, DeAngelis PM, Schjølberg AR, Røislien J, Mjåland O, Clausen OP. Burum-Auensen E, et al. Cell Prolif. 2008 Aug;41(4):645-59. doi: 10.1111/j.1365-2184.2008.00539.x. Cell Prolif. 2008. PMID: 18699967 Free PMC article.

Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer - PubMed (original) (raw)